The FDA approved the IN.PACT Admiral drug-coated balloon for peripheral arterial diseasein the superficial femoral artery and popliteal artery, Medtronic announced.
A technology using polymer beads to soak up inflammatory cytokines during heart-lung machine use for cardiac surgery has entered trials.
The heart failure drug eplerenone (Inspra) slowed the progressive cardiac damage of Duchenne muscular dystrophy in a small clinical trial.
Whole grains were linked to lower mortality, primarily from cardiovascular causes, in an analysis of large observational cohorts.
CardioBreak is a guide to what’s new and interesting on the Web for cardiologists and other healthcare professionals with an interest in cardiovascular disease, powered by the MedPage Today community. Got a tip? Send it to us: email@example.com.